<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">34713356</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>05</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1434-9949</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Clinical rheumatology</Title><ISOAbbreviation>Clin Rheumatol</ISOAbbreviation></Journal><ArticleTitle>Long COVID: rheumatologic/musculoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6&#xa0;months.</ArticleTitle><Pagination><StartPage>289</StartPage><EndPage>296</EndPage><MedlinePgn>289-296</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10067-021-05942-x</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To document the detailed characteristics including severity, type, and locations of rheumatic and musculoskeletal symptoms along with other COVID-19 persistent symptoms in hospitalized COVID-19 survivors at 3 and 6&#xa0;months.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this extension cohort study, two telephone surveys at 3 and 6&#xa0;months following the hospitalization were carried out. In these telephone surveys, participants were asked regarding their symptoms through a previously designed standard questionnaire.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">At 3&#xa0;months, 89.0% of survivors had at least one symptom, 74.6% had at least one rheumatic and musculoskeletal symptom, and 82.1% had at least one other COVID-19 symptom. At 6&#xa0;months, 59.6% of survivors had at least one symptom, 43.2% had at least one rheumatic and musculoskeletal symptom, and 51.2% had at least one other COVID-19 symptom. Regarding the rheumatic and musculoskeletal symptoms, 31.6% had fatigue, 18.6% had joint pain, and 15.1% had myalgia; and regarding the other-COVID-19-symptoms, 25.3% had dyspnea, 20.0% had hair loss, and 17.2% sweat at 6&#xa0;months. In an adjusted model, female patients were more likely to have fatigue (OR: 1.99, 95% CI: 1.18-3.34), myalgia (3.00, 1.51-5.98), and joint pain (3.39, 1.78-6.50) at 6&#xa0;months.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Approximately 3 in 5 patients had at least one symptom with &#x2248;2 in 5 patients had at least one rheumatic and musculoskeletal symptom. Fatigue, joint pain, and myalgia were the most frequent rheumatic and musculoskeletal symptoms. Joint pain and myalgia were mostly widespread. This information guide rheumatologists to understand the nature and features of persistent rheumatic and musculoskeletal symptoms in hospitalized COVID-19 survivors and may contribute to better management of these individuals. Key Points &#x2022; Approximately 3 in 5 patients had at least one symptom with &#x2248;2 in 5 patients had at least one rheumatic and musculoskeletal symptom at 6&#xa0;months &#x2022; Fatigue, joint pain, and myalgia were the most frequent rheumatic and musculoskeletal symptoms followed by back pain, low back pain, and neck pain &#x2022; Dyspnea, hair loss, and sweat were the most frequent other-COVID-19-symptoms.</AbstractText><CopyrightInformation>&#xa9; 2021. International League of Associations for Rheumatology (ILAR).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Karaarslan</LastName><ForeName>Fatih</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-1107-5887</Identifier><AffiliationInfo><Affiliation>Department of Medical Ecology and Hydroclimatology, Gulhane Training and Research Hospital, University of Health Sciences, Ankara, Turkey. fatih.karaarslan@sbu.edu.tr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xfc;neri</LastName><ForeName>Fulya Demircio&#x11f;lu</ForeName><Initials>FD</Initials><Identifier Source="ORCID">0000-0003-2469-0774</Identifier><AffiliationInfo><Affiliation>Department of Medical Ecology and Hydroclimatology, Gulhane Training and Research Hospital, University of Health Sciences, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karde&#x15f;</LastName><ForeName>Sinan</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-6311-8634</Identifier><AffiliationInfo><Affiliation>Department of Medical Ecology and Hydroclimatology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Clin Rheumatol</MedlineTA><NlmUniqueID>8211469</NlmUniqueID><ISSNLinking>0770-3198</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D018771" MajorTopicYN="N">Arthralgia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009140" MajorTopicYN="N">Musculoskeletal Diseases</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063806" MajorTopicYN="N">Myalgia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012216" MajorTopicYN="N">Rheumatic Diseases</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017741" MajorTopicYN="N">Survivors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Fatigue</Keyword><Keyword MajorTopicYN="N">Joint pain</Keyword><Keyword MajorTopicYN="N">Long-haul COVID</Keyword><Keyword MajorTopicYN="N">Muscle pain</Keyword><Keyword MajorTopicYN="N">Post-acute COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>We declare that we have no conflicts of interest regarding the submitted manuscript. Outside of the submitted manuscript SK has received congress travel, accommodation, and participation fee support (12th Anatolian Rheumatology Days) from AbbVie.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>10</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34713356</ArticleId><ArticleId IdType="pmc">PMC8553494</ArticleId><ArticleId IdType="doi">10.1007/s10067-021-05942-x</ArticleId><ArticleId IdType="pii">10.1007/s10067-021-05942-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Akintayo RO, Bahiri R, El Miedany Y, Olaosebikan H, Kalla AA, Adebajo AO, Migowa AN, Slimani S, Koussougbo OD, Kawther BA, Akpabio AA, Ghozlani I, Dey D, Hassan WA, Govind N, Makan K, Mohamed A, Genga EK, Ghassem MKA, Mortada M, Hamdi W, Wabi MO, Tikly M, Ngandeu-Singwe M, Scott C. African League Against Rheumatism (AFLAR) preliminary recommendations on the management of rheumatic diseases during the COVID-19 pandemic. Clin Rheumatol. 2020 doi: 10.1007/s10067-020-05355-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-020-05355-2</ArticleId><ArticleId IdType="pmc">PMC7465880</ArticleId><ArticleId IdType="pubmed">32876786</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Ringold S, Curtis JR, Michaud K, Johansson T, Yun H, Yazdany J, Schmajuk G. Effects of the SARS-CoV-2 global pandemic on U.S. rheumatology outpatient care delivery and use of telemedicine: an analysis of data from the RISE registry. Rheumatol Int. 2021 doi: 10.1007/s00296-021-04960-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-021-04960-x</ArticleId><ArticleId IdType="pmc">PMC8327041</ArticleId><ArticleId IdType="pubmed">34338816</ArticleId></ArticleIdList></Reference><Reference><Citation>Karde&#x15f; S, Erdem A, G&#xfc;rdal H. Public interest in musculoskeletal symptoms and disorders during the COVID-19 pandemic: Infodemiology study. Z Rheumatol. 2021 doi: 10.1007/s00393-021-00989-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00393-021-00989-2</ArticleId><ArticleId IdType="pmc">PMC8006118</ArticleId><ArticleId IdType="pubmed">33779835</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;nendi Z, Yurdakul FG, Bodur H, Cengiz AK, U&#xe7;ar &#xdc;, &#xc7;ay HF, &#x15e;en N, Keskin Y, G&#xfc;rer G, Meliko&#x11f;lu MA, Alt&#x131;nta&#x15f; D, Deveci H, Baykul M, Nas K, &#xc7;evik R, Karahan AY, Toprak M, Ketenci S, Nayimo&#x11f;lu M, Sezer &#x130;, Demir AN, Ecesoy H, Duru&#xf6;z MT, Yurdakul OV, Sar&#x131;fak&#x131;o&#x11f;lu AB, Ataman &#x15e;. The impact of COVID-19 on familial Mediterranean fever: a nationwide study. Rheumatol Int. 2021;41:1447&#x2013;1455. doi: 10.1007/s00296-021-04892-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-021-04892-6</ArticleId><ArticleId IdType="pmc">PMC8144686</ArticleId><ArticleId IdType="pubmed">34032894</ArticleId></ArticleIdList></Reference><Reference><Citation>Amengual O, Atsumi T. COVID-19 pandemic in Japan. Rheumatol Int. 2021;41(1):1&#x2013;5. doi: 10.1007/s00296-020-04744-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-020-04744-9</ArticleId><ArticleId IdType="pmc">PMC7671668</ArticleId><ArticleId IdType="pubmed">33205224</ArticleId></ArticleIdList></Reference><Reference><Citation>https://covid19.who.int/. Accessed on 5th of July 2021</Citation></Reference><Reference><Citation>Lerner AM, Robinson DA, Yang L, Williams CF, Newman LM, Breen JJ, Eisinger RW, Schneider JS, Adimora AA, Erbelding EJ (2021) Toward understanding COVID-19 recovery: National Institutes of Health Workshop on Postacute COVID-19. Ann Intern Med M21&#x2013;1043.10.7326/M21-1043</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8025940</ArticleId><ArticleId IdType="pubmed">33780290</ArticleId></ArticleIdList></Reference><Reference><Citation>https://meshb.nlm.nih.gov/record/ui?ui=C000711409/. Accessed on 12th of July 2021</Citation></Reference><Reference><Citation>Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, Doucet L, Berkani S, Oliosi E, Mallart E, Corre F, Zarrouk V, Moyer JD, Galy A, Honsel V, Fantin B, Nguyen Y. Postdischarge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020;81:e4&#x2013;e6. doi: 10.1016/j.jinf.2020.08.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.029</ArticleId><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Hermosillo JA, Mart&#xed;nez-L&#xf3;pez JP, Carrillo-Lamp&#xf3;n SA, Ruiz-Ojeda D, Herrera-Ram&#xed;rez S, Amezcua-Guerra LM, Mart&#xed;nez-Alvarado MDR. Post-Acute COVID-19 symptoms, a potential link with myalgic encephalomyelitis/chronic fatigue syndrome: a 6-month survey in a Mexican Cohort. Brain Sci. 2021;11(6):760. doi: 10.3390/brainsci11060760.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci11060760</ArticleId><ArticleId IdType="pmc">PMC8227652</ArticleId><ArticleId IdType="pubmed">34201087</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosn J, Piroth L, Epaulard O, Le Turnier P, Mentr&#xe9; F, Bachelet D, Laou&#xe9;nan C; French COVID cohort study and investigators groups (2021) Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort. Clin Microbiol Infect :S1198&#x2013;743X(21)00147&#x2013;6. 10.1016/j.cmi.2021.03.012</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8107834</ArticleId><ArticleId IdType="pubmed">34125067</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M, Palese A, Venturini M, De Martino M, Gerussi V, Graziano E, Bontempo G, Marrella F, Tommasini A, Fabris M, Curcio F, Isola M, Tascini C (2021) Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect:S1198&#x2013;743X(21)00281&#x2013;0. 10.1016/j.cmi.2021.05.033.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortini A, Torrigiani A, Sbaragli S, Lo Forte A, Crociani A, Cecchini P, InnocentiBruni G, Faraone A. COVID-19: persistence of symptoms and lung alterations after 3&#x2013;6 months from hospital discharge. Infection. 2021 doi: 10.1007/s15010-021-01638-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01638-1</ArticleId><ArticleId IdType="pmc">PMC8179958</ArticleId><ArticleId IdType="pubmed">34091869</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaarslan F, Demircio&#x11f;luG&#xfc;neri F, Karde&#x15f; S. Postdischarge rheumatic and musculoskeletal symptoms following hospitalization for COVID-19: prospective follow-up by phone interviews. Rheumatol Int. 2021;41(7):1263&#x2013;1271. doi: 10.1007/s00296-021-04882-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-021-04882-8</ArticleId><ArticleId IdType="pmc">PMC8114015</ArticleId><ArticleId IdType="pubmed">33978818</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandenbroucke JP, von Elm E, Altman DG, G&#xf8;tzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M, STROBE Initiative Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology. 2007;18(6):805&#x2013;835. doi: 10.1097/EDE.0b013e3181577511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0b013e3181577511</ArticleId><ArticleId IdType="pubmed">18049195</ArticleId></ArticleIdList></Reference><Reference><Citation>Misra DP, Zimba O, Gasparyan AY. Statistical data presentation: a primer for rheumatology researchers. Rheumatol Int. 2021;41(1):43&#x2013;55. doi: 10.1007/s00296-020-04740-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-020-04740-z</ArticleId><ArticleId IdType="pubmed">33201265</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Herck M, Goertz YMJ, Houben-Wilke S, Machado FVC, Meys R. Delbressine JM et al Severe fatigue in long COVID: follow-up study in members of online long COVID support groups. J Med Internet Res. 2021 doi: 10.2196/30274.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/30274</ArticleId><ArticleId IdType="pmc">PMC8457337</ArticleId><ArticleId IdType="pubmed">34494964</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes DL, Holdsworh L, Jawad N, Gunasekera P, Morice AH. Crooks MG Post-COVID-19 symptom burden: what is long-COVID and how should we manage it? Lung. 2021;199(2):113&#x2013;119. doi: 10.1007/s00408-021-00423-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-021-00423-z</ArticleId><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, Cook JR, Nordvig AS, Shalev D, Sehrawat TS, Ahluwalia N, Bikdeli B, Dietz D, Der-Nigoghossian C, Liyanage-Don N, Rosner GF, Bernstein EJ, Mohan S, Beckley AA, Seres DS, Choueiri TK, Uriel N, Ausiello JC, Accili D, Freedberg DE, Baldwin M, Schwartz A, Brodie D, Garcia CK, Elkind MSV, Connors JM, Bilezikian JP, Landry DW, Wan EY. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Oronsky B, Larson C, Hammond TC, Oronsky A, Kesari S, Lybeck M, Reid TR. A review of persistent post-COVID syndrome (PPCS) Clin Rev Allergy Immunol. 2021 doi: 10.1007/s12016-021-08848-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-021-08848-3</ArticleId><ArticleId IdType="pmc">PMC7896544</ArticleId><ArticleId IdType="pubmed">33609255</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>